Oramed Property Plant And Equipment Net from 2010 to 2024
ORMP Stock | USD 2.47 0.06 2.49% |
Property Plant And Equipment Net | First Reported 2007-11-30 | Previous Quarter 1.6 M | Current Value 1.4 M | Quarterly Volatility 584.7 K |
Check Oramed Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oramed main balance sheet or income statement drivers, such as Selling General Administrative of 16.7 M, Other Operating Expenses of 52.3 M or Research Development of 33.4 M, as well as many exotic indicators such as Price To Sales Ratio of 164, Dividend Yield of 0.0 or PTB Ratio of 2.92. Oramed financial statements analysis is a perfect complement when working with Oramed Pharmaceuticals Valuation or Volatility modules.
Oramed | Property Plant And Equipment Net |
Latest Oramed Pharmaceuticals' Property Plant And Equipment Net Growth Pattern
Below is the plot of the Property Plant And Equipment Net of Oramed Pharmaceuticals over the last few years. It is the total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production. Oramed Pharmaceuticals' Property Plant And Equipment Net historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Oramed Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Property Plant And Equipment Net | 10 Years Trend |
|
Property Plant And Equipment Net |
Timeline |
Oramed Property Plant And Equipment Net Regression Statistics
Arithmetic Mean | 486,253 | |
Geometric Mean | 41,753 | |
Coefficient Of Variation | 171.41 | |
Mean Deviation | 674,761 | |
Median | 17,000 | |
Standard Deviation | 833,491 | |
Sample Variance | 694.7B | |
Range | 2.2M | |
R-Value | 0.76 | |
Mean Square Error | 313.4B | |
R-Squared | 0.58 | |
Significance | 0.001 | |
Slope | 142,076 | |
Total Sum of Squares | 9.7T |
Oramed Property Plant And Equipment Net History
About Oramed Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Oramed Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Oramed Pharmaceuticals investors use historical funamental indicators, such as Oramed Pharmaceuticals's Property Plant And Equipment Net, to determine how well the company is positioned to perform in the future. Although Oramed Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Oramed Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Oramed Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Oramed Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Oramed Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Property Plant And Equipment Net | 2.1 M | 2.2 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Oramed Pharmaceuticals Correlation against competitors. To learn how to invest in Oramed Stock, please use our How to Invest in Oramed Pharmaceuticals guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Oramed Stock analysis
When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is Oramed Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oramed Pharmaceuticals. If investors know Oramed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oramed Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.26 | Revenue Per Share 0.017 | Quarterly Revenue Growth (1.00) | Return On Assets (0.05) | Return On Equity 0.0648 |
The market value of Oramed Pharmaceuticals is measured differently than its book value, which is the value of Oramed that is recorded on the company's balance sheet. Investors also form their own opinion of Oramed Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Oramed Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oramed Pharmaceuticals' market value can be influenced by many factors that don't directly affect Oramed Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oramed Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oramed Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oramed Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.